US Food and Drug Administration’s Adverse Event Reporting System—Highly Limited for Causal Inference in Dermatology

This viewpoint describes limitations of the US Food and Drug Administration’s Adverse Event Reporting System in dermatology literature.

Authors

Institutions

Publication Details

Journal
JAMA Dermatology
Published
2026-09-09
DOI
https://doi.org/10.1001/jamadermatol.2026.3075
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

US Food and Drug Administration’s Adverse Event Reporting System—Highly Limited for Causal Inference in Dermatology

D. Margolis, Charles Lu, Kaylin J. Beiter
JAMA Dermatology
Pharmacovigilance and Adverse Drug Reactions
article

US Food and Drug Administration’s Adverse Event Reporting System—Highly Limited for Causal Inference in Dermatology

D. Margolis, Charles Lu, Kaylin J. Beiter
article en

Abstract

This viewpoint describes limitations of the US Food and Drug Administration’s Adverse Event Reporting System in dermatology literature.

JAMA Dermatology
Johns Hopkins University (US), Johns Hopkins Medicine (US), University of Pennsylvania (US)
Zero hunger
Openalex Percentile: Top 12%
Pharmacovigilance and Adverse Drug Reactions
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

US Food and Drug Administration’s Adverse Event Reporting System—Highly Limited for Causal Inference in Dermatology — D. Margolis, Charles Lu, et al. · JAMA Dermatology (2026) | TGRS Research Map | TGRS